Emotra develops products in the field of psychiatry and psychology with the goal of providing treating physicians with more and better information. The company’s product, EDOR, is a psychophysiological test that identifies hyporeactive patients. Hyporeactivity among depressed patients functions as a biomarker describing a condition with greater risks, including for relapse in depression. Customers consist of specialist psychiatric clinics, university hospitals and research institutes. The company has its office at AstraZeneca BioVentureHub in Mölndal.
Company’s Keywords:
suicide, suicidology, suicide risk, electrodermal reactivity, psychology, psychiatric research, bipolar, unipolar
<2
<
<2013
Your request has been submitted successfully.
Own or work here?